Series A funding round for Areteia Therapeutics raising $75M in February 2024
Series A funding round for Areteia Therapeutics raising $75M in February 2024
| Investor | Firm Type | Partner |
|---|
Bain CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$425M
Top Valuation
-
Areteia Therapeutics raised $75M in a Series A round.
The round was announced on 02/01/24.
The round was led by Bain Capital Life Sciences, Adam Koppel.